| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
2 companies
Berman Ann E is a Director at IMRX, with reported holdings spanning 2 companies. Recent filings cover 3 purchases and 25 sales. Those positions are worth an estimated $144K at current prices.
Our model assigns Berman Ann E a below-average insider score of 43/100, based on 22 past trades. Over a 12-month horizon, 10.0% of those trades were profitable, with an average 12-month return of -17.9%.
Berman Ann E's largest disclosed position is in IMRX, worth about $144K. Net of sales, the recent Form 4 record there shows accumulation of 67,465 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 1, 2021 | L Loews Corp | Director | Sale+OE | 561 | $55.62 | $31,202.82 | -100% | -3.8% | +0.1% | |
| Aug 3, 2021 | IMRX Immuneering Corp | Director | Buy | 3,500 | $15.00 | $52,500.00 | New | +40.0% | -64.3% | |
| Jun 1, 2021 | L Loews Corp | Director | Sale+OE | 429 | $58.68 | $25,173.72 | -100% | -4.5% | +11.1% | |
| Mar 1, 2021 | L Loews Corp | Director | Sale+OE | 170 | $49.36 | $8,391.20 | -100% | - | - | |
| Mar 4, 2019 | L Loews Corp | Director | Sale+OE | 1,399 | $48.24 | $67,487.76 | -100% | - | - | |
| Nov 6, 2018 | L Loews Corp | Director | Sale+OE | 2,216 | $49.27 | $109,182.32 | -100% | - | - | |
| Dec 1, 2017 | L Loews Corp | Director | Sale+OE | 32 | $50.07 | $1,602.24 | -100% | - | - | |
| Nov 29, 2017 | L Loews Corp | Director | Sale+OE | 1,383 | $50.30 | $69,564.90 | -100% | - | - |